Several generic drug manufacturers are accused of price-fixing in a lawsuit; the state of Washington offers residents a universally available public option for health insurance; bills proposed by states to limit vaccine exemptions have stalled.
On Friday, 44 states filed a lawsuit that accused several pharmaceutical companies of inflating prices on drugs and making efforts to prevent competition, The Hill reported Saturday. The suit claims that 20 drug manufacturers engaged in price-fixing and had illegally collaborated to divide up the market and increase prices by as much as 1000%. One company, Teva, which denied wrongdoing, was placed at the heart of the controversy and was accused of conspiring to raise prices of 86 drugs between July 2013 and January 2015.
The state of Washington has worked to make a public option for health insurance universally available for its residents, The New York Times reported. The plan was approved last month by state legislature and Governor Jay Inslee is expected to sign it into law today. Prices of a set of tiered plans, which would cover standard services, are expected to be 10% less expensive than comparable private insurance plans.
As the current measles outbreak has rapidly become the worst in decades, state legislatures have failed to limit exemptions that allow families to avoid vaccinating their children, according to The Pew Charitable Trusts. While states such as Arizona, Hawaii, Iowa, and New York had previously proposed bills to remove exemptions, they have either stalled in committee or failed to advance. The CDC has reported 764 measles infections in 23 states this year alone, far eclipsing numbers from recent years.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More